Ethical view of sedation in palliative care;Aspectos éticos de la sedación en cuidados paliativos

Medicina Paliativa

Volumn 9, Issue 1, 2002, Pages 41-46

  Porta i Sales, J ^a   Nunez Olarte J M ^a   Altisent Trota, R ^a   Gisbert Aguilar, A ^a   Loncan Vidal, P ^a   Munoz Sanchez D ^a   Novellas Aguirre De Carcer A ^a   Rivas Flores, J ^a   Rodeles Del Pozo, R ^a   Vilches Aguirre, Y ^a   Sanz Ortiz, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOMETHIAZOLE; DIAZEPAM; HALOPERIDOL; LEVOMEPROMAZINE; MIDAZOLAM; MORPHINE; PHENOBARBITAL; SEDATIVE AGENT;

DRUG CHOICE; HUMAN; MEDICAL ETHICS; PALLIATIVE THERAPY; PRACTICE GUIDELINE; REVIEW; SEDATION; TERMINAL CARE; TREATMENT INDICATION;

EID: 0036090992     PISSN: 1134248X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Definición y opìniones acerca de la sedación terminal: Estudio múlticéntrico catalano-balear
2. Sedation in the management of refractory symptoms: Guidelines for evaluation and treatment
3. Slow euthanasia
4. Symptom prevalence and control during cancer patients' last days of life
5. Drug-induced terminal sedation for symptom control
6. Sedation and terminal Care
7. Palliative sedation defined or why and when terminal sedation is not euthanasia
8. Estudio multicéntrico catalano-balear sobre la sedación terminal en Cuidados Paliativos
9. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients
10. Sedation for delirium and other symptoms in terminally ill patients in Edmonton
11. Ocurrence, causes, and outcome of delirium in patients with advanced cancer
12. Symptom prevalence in the last week of life
13. Commentary on "Slow Euthanasia"
14. Morphine drips, terminal sedation, and slow euthanasia: Definitions and facts, not anecdotes
15. Sedación con midazolam. Eficacia de un protocolo de tratamiento en pacientes terminales con síntomas no controlables con otros medios
16. A comparison of the use of sedatives in a hospital support team and in a hospice
17. Opioid use in the last week of life and implications for end of life decission making
18. Symptom control and the need for sedation during the treatment in Tel Hashomer inpatient hospice
19. Effects of high dose opioids and sedatives on survival on terminally ill cancer patients
20. Artificial hydration and nutrition at the end of life
21. Guidelines on artificial nutrition versus hydration in terminal cancer patients
22. Parámetros biológicos y supervivencia en pacientes con neoplasias en situación avanzada y terminal
23. The Palliative Pronostic Index: A scoring system for survival prediction of terminally ill cancer patients
24. Successful validation of Palliative Prognostic Score in terminally ill cancer patients
25. Deshydration and the dying patient
26. The sensation of thirst in dying patients recieving IV hydration
27. Manifestaciones clínicas y biológicas de la deshidratación en el enfermo en fase terminal
28. Determinants of the sensation of thirst in terminally ill cancer patients
29. The effects of fluid status and fluid therapy on the dying: A systematic review